Unpublished research using Canadian data has reportedly found that individuals who received the seasonal flu vaccine last year are twice as likely to catch H1N1. The CDC has stated that it has not had similar findings in the US.
WHO stated that regulatory authorities have licensed H1N1 vaccines in Australia, China, Hungary and the United States. Japan and several European countries will soon license vaccines.
WHO reported that drug makers can only produce enough H1N1 vaccine each year for half the planet because they lack factory capacity.
Researchers have reported that the injectable H1N1 vaccine is twice as protective as the inhaled nasal spray version of the vaccine.
Photo taken from: http://www.telegraph.co.uk/health/healthnews/5806751/Swine-flu-vaccine-to-be-given-to-entire-population.html
HealthMap brings together disparate data sources to achieve a unified and comprehensive view of the current global state of infectious diseases and their effect on human and animal health. This freely available Web site integrates outbreak data of varying reliability, ranging from news sources (such as Google News) to curated personal accounts (such as ProMED) to validated official alerts (such as World Health Organization). Through an automated text processing system, the data is aggregated by disease and displayed by location for user-friendly access to the original alert. HealthMap provides a jumping-off point for real-time information on emerging infectious diseases and has particular interest for public health officials and international travelers.
Posts
No comments:
Post a Comment